This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2017 Nov 7;318(17):1647-1648.

doi: 10.1001/jama.2017.14155.

Targeting Immune Checkpoints in Cancer Therapy

Suzanne L Topalian^{1

2}

Affiliations

Affiliations

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² The Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.

PMID: 28885639
DOI: 10.1001/jama.2017.14155

Targeting Immune Checkpoints in Cancer Therapy

Suzanne L Topalian. JAMA. 2017.

. 2017 Nov 7;318(17):1647-1648.

doi: 10.1001/jama.2017.14155.

Author

Suzanne L Topalian^{1

2}

Affiliations

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² The Johns Hopkins Bloomberg~Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland.

PMID: 28885639
DOI: 10.1001/jama.2017.14155

No abstract available

PubMed Disclaimer

Similar articles

Programmed death 1 (PD-1) and its ligand (PD-L1) as a new frontier in cancer Immunotherapy and challenges for the Pathologist: state of the art.
Callea M, Pedica F, Doglioni C. Callea M, et al. Pathologica. 2016 Jun;108(2):48-58. Pathologica. 2016. PMID: 28195250 Review.
Approvals in 2016: the march of the checkpoint inhibitors.
Blumenthal GM, Pazdur R. Blumenthal GM, et al. Nat Rev Clin Oncol. 2017 Feb 20;14(3):131-132. doi: 10.1038/nrclinonc.2017.15. Nat Rev Clin Oncol. 2017. PMID: 28218255 No abstract available.
PD-L1 Expression in Pancreatic Cancer.
Zheng L. Zheng L. J Natl Cancer Inst. 2017 Jan 28;109(6):djw304. doi: 10.1093/jnci/djw304. Print 2017 Jan. J Natl Cancer Inst. 2017. PMID: 28131993 Free PMC article. No abstract available.
Rational Discovery of Response Biomarkers: Candidate Prognostic Factors and Biomarkers for Checkpoint Inhibitor-Based Immunotherapy.
Hou Q, Xu H. Hou Q, et al. Adv Exp Med Biol. 2020;1248:143-166. doi: 10.1007/978-981-15-3266-5_7. Adv Exp Med Biol. 2020. PMID: 32185710 Review.
Editorial: Development of Anticancer Reagents.
Liu X. Liu X. Comb Chem High Throughput Screen. 2017;20(5):356. doi: 10.2174/138620732005170907162907. Comb Chem High Throughput Screen. 2017. PMID: 29050547 No abstract available.

See all similar articles

Cited by

Tumor suppressor ACER1 correlates with prognosis and Immune Infiltration in head and neck squamous cell carcinoma.
Liu Z, Yang X, Chen S, Jia W, Qian Y, Zhang M, Fang T, Liu H, Yang H. Liu Z, et al. Sci Rep. 2024 Nov 14;14(1):28039. doi: 10.1038/s41598-024-78663-1. Sci Rep. 2024. PMID: 39543336 Free PMC article.
Neuromedin U receptor 1 deletion leads to impaired immunotherapy response and high malignancy in colorectal cancer.
Zhou Y, Zhang X, Gao Y, Peng Y, Liu P, Chen Y, Guo C, Deng G, Ouyang Y, Zhang Y, Han Y, Cai C, Shen H, Gao L, Zeng S. Zhou Y, et al. iScience. 2024 Jun 20;27(7):110318. doi: 10.1016/j.isci.2024.110318. eCollection 2024 Jul 19. iScience. 2024. PMID: 39055918 Free PMC article.
Comprehensive pan-cancer analysis reveals that C5orf34 regulates the proliferation and mortality of lung cancer.
Yang M, Deng Y, Ma Y, Song C, Wu Z, Yibulayin X, Sun X, Guo Y, He D. Yang M, et al. Funct Integr Genomics. 2024 Jun 29;24(4):119. doi: 10.1007/s10142-024-01397-w. Funct Integr Genomics. 2024. PMID: 38951221
Establishing a carcinoembryonic antigen-associated competitive endogenous RNA network and forecasting an important regulatory axis in colon adenocarcinoma patients.
Liang F, Xu Y, Zheng H, Tang W. Liang F, et al. J Gastrointest Oncol. 2024 Feb 29;15(1):220-236. doi: 10.21037/jgo-24-43. Epub 2024 Feb 28. J Gastrointest Oncol. 2024. PMID: 38482222 Free PMC article.
A novel ferroptosis-related gene signature for overall survival prediction in patients with gastric cancer.
Wen F, Zhao F, Huang W, Liang Y, Sun R, Lin Y, Zhang W. Wen F, et al. Sci Rep. 2024 Feb 23;14(1):4422. doi: 10.1038/s41598-024-53515-0. Sci Rep. 2024. PMID: 38388534 Free PMC article.

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Research Materials
- NCI CPTC Antibody Characterization Program